Global AI Pharma Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2207200006 | Category: Service & Software | Pages: 123 | Format: PDF | Published Date: August 23,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The AI Pharma market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global AI Pharma market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Preclinical Stage (Optimization of Lead Compounds, etc.) accounting for  % of the AI Pharma global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While Self-developed Oipeline segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of AI Pharma include Recursion, Insilico Medicine, Exscientia, BenevolentAI, and Atomwise, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
AI Pharma market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Self-developed Oipeline
    Contract Research Organization (CRO)
    Other
Market segment by Application, can be divided into
    Preclinical Stage (Optimization of Lead Compounds, etc.)
    Clinical Trial Phase (Predicting Treatment Outcome, etc.)
Market segment by players, this report covers
    Recursion
    Insilico Medicine
    Exscientia
    BenevolentAI
    Atomwise
    Roivant Sciences
    Schrödinger
    Lantern Pharma
    XtalPi
    Landos Biopharma
    Relay Therapeutics
    Accutar Biotech
    Deep Genomics
    Oncocross
    AI Therapeutics
    BioMap
    METiS Pharmaceuticals
    NeoX Biotech
    StoneWise
    Deep Intelligent Pharma
    Gigaceuticals
    Chemical.AI
    Artivila
    Galixir
    Xbiome
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe AI Pharma product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of AI Pharma, with revenue, gross margin and global market share of AI Pharma from 2019 to 2022.
Chapter 3, the AI Pharma competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and AI Pharma market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe AI Pharma research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of AI Pharma
    1.2 Classification of AI Pharma by Type
        1.2.1 Overview: Global AI Pharma Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global AI Pharma Revenue Market Share by Type in 2021
        1.2.3 Self-developed Oipeline
        1.2.4 Contract Research Organization (CRO)
        1.2.5 Other
    1.3 Global AI Pharma Market by Application
        1.3.1 Overview: Global AI Pharma Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Preclinical Stage (Optimization of Lead Compounds, etc.)
        1.3.3 Clinical Trial Phase (Predicting Treatment Outcome, etc.)
    1.4 Global AI Pharma Market Size & Forecast
    1.5 Global AI Pharma Market Size and Forecast by Region
        1.5.1 Global AI Pharma Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global AI Pharma Market Size by Region, (2017-2022)
        1.5.3 North America AI Pharma Market Size and Prospect (2017-2028)
        1.5.4 Europe AI Pharma Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific AI Pharma Market Size and Prospect (2017-2028)
        1.5.6 South America AI Pharma Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa AI Pharma Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 AI Pharma Market Drivers
        1.6.2 AI Pharma Market Restraints
        1.6.3 AI Pharma Trends Analysis
2 Company Profiles
    2.1 Recursion
        2.1.1 Recursion Details
        2.1.2 Recursion Major Business
        2.1.3 Recursion AI Pharma Product and Solutions
        2.1.4 Recursion AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Recursion Recent Developments and Future Plans
    2.2 Insilico Medicine
        2.2.1 Insilico Medicine Details
        2.2.2 Insilico Medicine Major Business
        2.2.3 Insilico Medicine AI Pharma Product and Solutions
        2.2.4 Insilico Medicine AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Insilico Medicine Recent Developments and Future Plans
    2.3 Exscientia
        2.3.1 Exscientia Details
        2.3.2 Exscientia Major Business
        2.3.3 Exscientia AI Pharma Product and Solutions
        2.3.4 Exscientia AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Exscientia Recent Developments and Future Plans
    2.4 BenevolentAI
        2.4.1 BenevolentAI Details
        2.4.2 BenevolentAI Major Business
        2.4.3 BenevolentAI AI Pharma Product and Solutions
        2.4.4 BenevolentAI AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 BenevolentAI Recent Developments and Future Plans
    2.5 Atomwise
        2.5.1 Atomwise Details
        2.5.2 Atomwise Major Business
        2.5.3 Atomwise AI Pharma Product and Solutions
        2.5.4 Atomwise AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Atomwise Recent Developments and Future Plans
    2.6 Roivant Sciences
        2.6.1 Roivant Sciences Details
        2.6.2 Roivant Sciences Major Business
        2.6.3 Roivant Sciences AI Pharma Product and Solutions
        2.6.4 Roivant Sciences AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Roivant Sciences Recent Developments and Future Plans
    2.7 Schrödinger
        2.7.1 Schrödinger Details
        2.7.2 Schrödinger Major Business
        2.7.3 Schrödinger AI Pharma Product and Solutions
        2.7.4 Schrödinger AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Schrödinger Recent Developments and Future Plans
    2.8 Lantern Pharma
        2.8.1 Lantern Pharma Details
        2.8.2 Lantern Pharma Major Business
        2.8.3 Lantern Pharma AI Pharma Product and Solutions
        2.8.4 Lantern Pharma AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Lantern Pharma Recent Developments and Future Plans
    2.9 XtalPi
        2.9.1 XtalPi Details
        2.9.2 XtalPi Major Business
        2.9.3 XtalPi AI Pharma Product and Solutions
        2.9.4 XtalPi AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 XtalPi Recent Developments and Future Plans
    2.10 Landos Biopharma 
        2.10.1 Landos Biopharma Details
        2.10.2 Landos Biopharma Major Business
        2.10.3 Landos Biopharma AI Pharma Product and Solutions
        2.10.4 Landos Biopharma AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Landos Biopharma Recent Developments and Future Plans
    2.11 Relay Therapeutics
        2.11.1 Relay Therapeutics Details
        2.11.2 Relay Therapeutics Major Business
        2.11.3 Relay Therapeutics AI Pharma Product and Solutions
        2.11.4 Relay Therapeutics AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Relay Therapeutics Recent Developments and Future Plans
    2.12 Accutar Biotech
        2.12.1 Accutar Biotech Details
        2.12.2 Accutar Biotech Major Business
        2.12.3 Accutar Biotech AI Pharma Product and Solutions
        2.12.4 Accutar Biotech AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Accutar Biotech Recent Developments and Future Plans
    2.13 Deep Genomics
        2.13.1 Deep Genomics Details
        2.13.2 Deep Genomics Major Business
        2.13.3 Deep Genomics AI Pharma Product and Solutions
        2.13.4 Deep Genomics AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Deep Genomics Recent Developments and Future Plans
    2.14 Oncocross
        2.14.1 Oncocross Details
        2.14.2 Oncocross Major Business
        2.14.3 Oncocross AI Pharma Product and Solutions
        2.14.4 Oncocross AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Oncocross Recent Developments and Future Plans
    2.15 AI Therapeutics
        2.15.1 AI Therapeutics Details
        2.15.2 AI Therapeutics Major Business
        2.15.3 AI Therapeutics AI Pharma Product and Solutions
        2.15.4 AI Therapeutics AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 AI Therapeutics Recent Developments and Future Plans
    2.16 BioMap
        2.16.1 BioMap Details
        2.16.2 BioMap Major Business
        2.16.3 BioMap AI Pharma Product and Solutions
        2.16.4 BioMap AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 BioMap Recent Developments and Future Plans
    2.17 METiS Pharmaceuticals
        2.17.1 METiS Pharmaceuticals Details
        2.17.2 METiS Pharmaceuticals Major Business
        2.17.3 METiS Pharmaceuticals AI Pharma Product and Solutions
        2.17.4 METiS Pharmaceuticals AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.17.5 METiS Pharmaceuticals Recent Developments and Future Plans
    2.18 NeoX Biotech
        2.18.1 NeoX Biotech Details
        2.18.2 NeoX Biotech Major Business
        2.18.3 NeoX Biotech AI Pharma Product and Solutions
        2.18.4 NeoX Biotech AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.18.5 NeoX Biotech Recent Developments and Future Plans
    2.19 StoneWise
        2.19.1 StoneWise Details
        2.19.2 StoneWise Major Business
        2.19.3 StoneWise AI Pharma Product and Solutions
        2.19.4 StoneWise AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.19.5 StoneWise Recent Developments and Future Plans
    2.20 Deep Intelligent Pharma
        2.20.1 Deep Intelligent Pharma Details
        2.20.2 Deep Intelligent Pharma Major Business
        2.20.3 Deep Intelligent Pharma AI Pharma Product and Solutions
        2.20.4 Deep Intelligent Pharma AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.20.5 Deep Intelligent Pharma Recent Developments and Future Plans
    2.21 Gigaceuticals
        2.21.1 Gigaceuticals Details
        2.21.2 Gigaceuticals Major Business
        2.21.3 Gigaceuticals AI Pharma Product and Solutions
        2.21.4 Gigaceuticals AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.21.5 Gigaceuticals Recent Developments and Future Plans
    2.22 Chemical.AI
        2.22.1 Chemical.AI Details
        2.22.2 Chemical.AI Major Business
        2.22.3 Chemical.AI AI Pharma Product and Solutions
        2.22.4 Chemical.AI AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.22.5 Chemical.AI Recent Developments and Future Plans
    2.23 Artivila
        2.23.1 Artivila Details
        2.23.2 Artivila Major Business
        2.23.3 Artivila AI Pharma Product and Solutions
        2.23.4 Artivila AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.23.5 Artivila Recent Developments and Future Plans
    2.24 Galixir
        2.24.1 Galixir Details
        2.24.2 Galixir Major Business
        2.24.3 Galixir AI Pharma Product and Solutions
        2.24.4 Galixir AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.24.5 Galixir Recent Developments and Future Plans
    2.25 Xbiome
        2.25.1 Xbiome Details
        2.25.2 Xbiome Major Business
        2.25.3 Xbiome AI Pharma Product and Solutions
        2.25.4 Xbiome AI Pharma Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.25.5 Xbiome Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global AI Pharma Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 AI Pharma Players Market Share in 2021
        3.2.2 Top 10 AI Pharma Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 AI Pharma Players Head Office, Products and Services Provided
    3.4 AI Pharma Mergers & Acquisitions
    3.5 AI Pharma New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global AI Pharma Revenue and Market Share by Type (2017-2022)
    4.2 Global AI Pharma Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global AI Pharma Revenue Market Share by Application (2017-2022)
    5.2 Global AI Pharma Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America AI Pharma Revenue by Type (2017-2028)
    6.2 North America AI Pharma Revenue by Application (2017-2028)
    6.3 North America AI Pharma Market Size by Country
        6.3.1 North America AI Pharma Revenue by Country (2017-2028)
        6.3.2 United States AI Pharma Market Size and Forecast (2017-2028)
        6.3.3 Canada AI Pharma Market Size and Forecast (2017-2028)
        6.3.4 Mexico AI Pharma Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe AI Pharma Revenue by Type (2017-2028)
    7.2 Europe AI Pharma Revenue by Application (2017-2028)
    7.3 Europe AI Pharma Market Size by Country
        7.3.1 Europe AI Pharma Revenue by Country (2017-2028)
        7.3.2 Germany AI Pharma Market Size and Forecast (2017-2028)
        7.3.3 France AI Pharma Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom AI Pharma Market Size and Forecast (2017-2028)
        7.3.5 Russia AI Pharma Market Size and Forecast (2017-2028)
        7.3.6 Italy AI Pharma Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific AI Pharma Revenue by Type (2017-2028)
    8.2 Asia-Pacific AI Pharma Revenue by Application (2017-2028)
    8.3 Asia-Pacific AI Pharma Market Size by Region
        8.3.1 Asia-Pacific AI Pharma Revenue by Region (2017-2028)
        8.3.2 China AI Pharma Market Size and Forecast (2017-2028)
        8.3.3 Japan AI Pharma Market Size and Forecast (2017-2028)
        8.3.4 South Korea AI Pharma Market Size and Forecast (2017-2028)
        8.3.5 India AI Pharma Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia AI Pharma Market Size and Forecast (2017-2028)
        8.3.7 Australia AI Pharma Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America AI Pharma Revenue by Type (2017-2028)
    9.2 South America AI Pharma Revenue by Application (2017-2028)
    9.3 South America AI Pharma Market Size by Country
        9.3.1 South America AI Pharma Revenue by Country (2017-2028)
        9.3.2 Brazil AI Pharma Market Size and Forecast (2017-2028)
        9.3.3 Argentina AI Pharma Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa AI Pharma Revenue by Type (2017-2028)
    10.2 Middle East & Africa AI Pharma Revenue by Application (2017-2028)
    10.3 Middle East & Africa AI Pharma Market Size by Country
        10.3.1 Middle East & Africa AI Pharma Revenue by Country (2017-2028)
        10.3.2 Turkey AI Pharma Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia AI Pharma Market Size and Forecast (2017-2028)
        10.3.4 UAE AI Pharma Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global AI Pharma Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?